This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: Journals

JTH Editors Preview November Issue

Thursday, October 26, 2017   (0 Comments)
Posted by: Luke Blount
Share |

The Journal of Thrombosis and Haemostasis (JTH) Editors Pieter Reitsma and Frits Rosendaal highlighted three articles in the upcoming November issue. From the editors:

This month's review article by Greinacher and colleagues is on autoimmune heparin-induced thrombocytopenia. Besides what the name suggests, this immunological disorder leads to thrombocytopenia in patients who were not exposed to heparin, and the responsible antibodies do activate platelets in the absence of heparin.

We also would like to highlight an article by Halton and colleagues that reports a phase II study of dabigatran in children with venous thrombosis. The results of this study will help to make treatment of children with synthetic direct oral anticoagulants safer.

Finally, Gleeson and colleagues address the cytoprotective effects of protease activated receptor I using an original protein C-factor VII chimeric protein.


Membership Management Software Powered by YourMembership  ::  Legal